Short interest for Titan Pharma gives investors a sense of the degree to which investors are betting on the decline of Titan Pharma's stock. Short interest data is updated every two weeks.

Titan Pharma Stock (NASDAQ:TTNP), Short Interest Report

TITAN PHARMA INC

Titan Pharmaceuticals

Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AEHL

AGEN

AIRC

ALCC

AMRK

ARRW

AUUD

AXTI

BCAN

CCTG

CNFR

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

COIN

DATS

DELL

DOGZ

DXYZ

FSLY

GLMD

HUBC

LGVN

MDIA

MESO

MODN

MRNO

MSTR

PARA

PERI

PLOW

PPTA

RELI

SLNA

SPCB

TCON

TPCS

TTNP

UCAR

XXII

ZOOZ

Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session.

Agenus disclosed a 1-for-20 reverse stock split of common stock.

Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on Monday.

Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Earnings

Eurozone

Commodities

Global

FBIO

MBOT

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 50 points on Friday.

The Dow traded down 0.17% to 37,644.68 while the NASDAQ fell 0.48% to 15,022.70. The S&amp;P 500 also fell, dropping, 0.33% to 4,767.78.

Gold Moves Lower; Microbot Medical Shares Slide

Pre-Market Outlook

AAOI

ADTX

BBLG

BKYI

BTDR

BYND

CING

ENVB

FLYX

FTFT

GRFS

Kintara Therapeutics, Inc. - Common Stock

KTRA

LVLU

MDRR

NVFY

PRTC

SIDU

SNES

SNTG

SXTC

TELL

WULF

YCBD

ZJYL

Shares of  Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update.

Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Titan Pharmaceuticals, Inc. - Common Stock

Titan Pharmaceuticals Inc

Titan Pharmaceuticals Inc Warrants - Class B (18/10/2024)

<h3>Gainers</h3>
<ul>
<li>CareCloud (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCLD#NASDAQ">CCLD</a>) stock moved upwards by 80.5% to $2.27 during Monday's regular session. The company's market cap stands at $36.6 million. </li>
<li>Novavax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) stock rose 42.17% to $12.62. The market value of their outstanding shares is at $1.7 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Macrogenics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) stock rose 27.79% to $4.23. The market value of their outstanding shares is at $264.6 million. As per the news, the Q1 earnings report came out 2 days ago. </li>
<li>Chromocell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#AMEX">CHRO</a>) shares moved upwards by 25.68% to $2.3. The market value of their outstanding shares is at $13.5 million. </li>
<li>Omega Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMGA#NASDAQ">OMGA</a>) shares moved upwards by 24.01% to $2.43. The market value of their outstanding shares is at $134.0 million. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares increased by 21.74% to $8.4. The market value of their outstanding shares is at $7.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) shares declined by 40.1% to $0.84 during Monday's regular session. The company's market cap stands at $5.1 million. </li>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) stock fell 22.03% to $2.69. The market value of their outstanding shares is at $2.3 million. The company's, Q2 earnings came out yesterday. </li>
<li>Heart Test Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSCS#NASDAQ">HSCS</a>) stock declined by 19.66% to $0.07. The company's market cap stands at $4.6 million. </li>
<li>Benitec Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTC#NASDAQ">BNTC</a>) shares decreased by 16.76% to $7.7. The market value of their outstanding shares is at $65.4 million. As per the press release, Q3 earnings came out today. </li>
<li>Oragenics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#AMEX">OGEN</a>) stock declined by 16.12% to $1.54. The market value of their outstanding shares is at $6.9 million. </li>
<li>Fortrea Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) shares declined by 15.78% to $27.82. The company's market cap stands at $2.4 billion. The company's, Q1 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APDN

BNTC

CCLD

CHRO

FTRE

HSCS

MGNX

NVAX

OGEN

OMGA

RNAZ

12 Health Care Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>NRX Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) shares increased by 39.5% to $2.93 during Monday's regular session. The company's market cap stands at $30.9 million. </li>
<li>TC BioPharm (Holdings) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) stock moved upwards by 35.61% to $1.98. The company's market cap stands at $6.3 million. </li>
<li>Outset Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OM#NASDAQ">OM</a>) stock rose 26.15% to $3.96. The company's market cap stands at $204.8 million. </li>
<li>Nanoviricides (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NNVC#AMEX">NNVC</a>) stock moved upwards by 25.66% to $1.42. The market value of their outstanding shares is at $16.7 million. </li>
<li>Chemomab Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMMB#NASDAQ">CMMB</a>) stock rose 22.16% to $0.9. The market value of their outstanding shares is at $12.8 million. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares moved upwards by 22.09% to $8.4. The market value of their outstanding shares is at $7.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lyra Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYRA#NASDAQ">LYRA</a>) shares decreased by 86.3% to $0.55 during Monday's regular session. The market value of their outstanding shares is at $33.6 million. As per the news, the Q1 earnings report came out 4 days ago. </li>
<li>GlycoMimetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLYC#NASDAQ">GLYC</a>) stock declined by 79.04% to $0.38. The market value of their outstanding shares is at $24.7 million. </li>
<li>EyePoint Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYPT#NASDAQ">EYPT</a>) shares declined by 39.37% to $11.97. The market value of their outstanding shares is at $623.4 million. </li>
<li>Acutus Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFIB#NASDAQ">AFIB</a>) stock fell 27.1% to $0.11. The company's market cap stands at $3.1 million. </li>
<li>Integra Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) shares declined by 20.46% to $22.98. The company's market cap stands at $1.8 billion. The company's, Q1 earnings came out today. </li>
<li>Helius Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) shares fell 14.81% to $2.44. The company's market cap stands at $2.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AFIB

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

EYPT

GLYC

HSDT

IART

LYRA

NNVC

NRXP

TCBP

<h3>Gainers</h3>
<ul>
<li>Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) stock moved upwards by 98.4% to $3.83 during Thursday's regular session. The company's market cap stands at $200.6 million. The company's, Q1 earnings came out yesterday. </li>
<li>Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) stock moved upwards by 40.1% to $0.19. The market value of their outstanding shares is at $1.2 million. </li>
<li>Sensei Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNSE#NASDAQ">SNSE</a>) shares increased by 40.05% to $1.76. The company's market cap stands at $44.2 million. </li>
<li>Syra Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) shares rose 36.26% to $1.42. The company's market cap stands at $9.3 million. </li>
<li>Jaguar Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) shares moved upwards by 32.35% to $0.3. The company's market cap stands at $85.5 million. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares moved upwards by 25.37% to $8.4. The market value of their outstanding shares is at $7.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Accuray (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAY#NASDAQ">ARAY</a>) shares fell 27.6% to $1.57 during Thursday's regular session. The market value of their outstanding shares is at $155.6 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Metagenomi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGX#NASDAQ">MGX</a>) shares fell 17.62% to $5.8. The market value of their outstanding shares is at $217.3 million. </li>
<li>Elevation Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELEV#NASDAQ">ELEV</a>) stock fell 11.26% to $3.55. The company's market cap stands at $172.7 million. The company's, Q1 earnings came out today. </li>
<li>Bruker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRKR#NASDAQ">BRKR</a>) stock fell 11.13% to $70.24. The company's market cap stands at $10.2 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Ocean Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCEA#NASDAQ">OCEA</a>) stock fell 10.97% to $1.34. The company's market cap stands at $46.4 million. </li>
<li>BioAtla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAB#NASDAQ">BCAB</a>) stock declined by 10.84% to $3.0. The market value of their outstanding shares is at $144.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARAY

BCAB

BRKR

ELEV

JAGX

NUWE

OCEA

SNSE

SYRA

12 Health Care Stocks Moving In Thursday's Intraday Session

Offerings

Titan Pharmaceuticals Files FormRW Co Decided Not To Pursue The Offering Due To Market Conditions And No Longer Wishes To Conduct A Public Offering Of Securities At This Time, No Securities Covered By The Registration Statement Have Been Issued Or Sold.

<h3>Gainers</h3>
<ul>
<li>Mobile-health Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDR#NASDAQ">MNDR</a>) shares rose 15.0% to $31.35 during Friday's after-market session. The company's market cap stands at $1.0 billion. </li>
<li>Galera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRTX#NASDAQ">GRTX</a>) stock increased by 9.13% to $0.2. The market value of their outstanding shares is at $10.9 million. </li>
<li>Innovative Eyewear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>) shares increased by 8.54% to $0.26. The company's market cap stands at $3.4 million. </li>
<li>China Pharma Holdings, Inc. Common Stock (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CPHI#AMEX">CPHI</a>) stock moved upwards by 6.7% to $0.34. </li>
<li>Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) shares increased by 6.17% to $0.17. The market value of their outstanding shares is at $8.4 million. </li>
<li>Adaptimmune Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAP#NASDAQ">ADAP</a>) shares increased by 6.04% to $1.04. The company's market cap stands at $264.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vaxxinity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VAXX#NASDAQ">VAXX</a>) shares decreased by 10.7% to $0.43 during Friday's after-market session. The company's market cap stands at $53.8 million. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) stock declined by 9.26% to $6.37. The market value of their outstanding shares is at $5.8 million. </li>
<li>Tiziana Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLSA#NASDAQ">TLSA</a>) shares decreased by 8.24% to $0.61. The company's market cap stands at $61.4 million. </li>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) shares decreased by 7.17% to $0.4. The market value of their outstanding shares is at $4.2 million. </li>
<li>Clene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) stock decreased by 6.94% to $0.33. The company's market cap stands at $41.7 million. </li>
<li>Metagenomi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGX#NASDAQ">MGX</a>) stock fell 5.67% to $6.5. The market value of their outstanding shares is at $243.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADAP

CLDI

CLNN

CPHI

GRTX

LUCY

MNDR

SNGX

TLSA

VAXX

12 Health Care Stocks Moving In Friday's After-Market Session

Shares of Agenus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agen#NASDAQ">AGEN</a>) fell sharply during Monday&rsquo;s session.
Agenus disclosed a 1-for-20 reverse stock split of common stock.
Agenus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agen#NASDAQ">AGEN</a>) declined 17% to $0.4181 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Auddia Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auud#NASDAQ">AUUD</a>) shares jumped 231.7% to $4.72 after the company announced the USPTO awarded it with U.S. Patent 11,935,520 for the core AI technology the company uses in its flagship faidr app to deliver ad-free AM/FM radio stations to paid subscribers.</li>
<li>Longeveron Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvn#NASDAQ">LGVN</a>) shares climbed 93.2% to $4.2499 after the company submitted paperwork for a share offering.</li>
<li>UTime Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wto#NASDAQ">WTO</a>) gained 56.8% to $0.29 after the company completed a private placement.</li>
<li>U Power Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ucar#NASDAQ">UCAR</a>) climbed 48% to $6.96 after the company announced announced that its battery-swapping and sharing model for two-wheeled and light four-wheeled electric vehicles is poised for a formal commercial rollout in Wuhu, Anhui Province, China.</li>
<li>Arrowroot Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arrw#NASDAQ">ARRW</a>) rose 38.2% to $19.53.</li>
<li>Destiny Tech100 Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dxyz#NASDAQ">DXYZ</a>) jumped 33.8% to $79.30 after jumping around 77% on Friday.</li>
<li>TechPrecision Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tpcs#NASDAQ">TPCS</a>) rose 29.8% to $4.2837 after the company announced the termination of the agreement to acquire Votaw Precision Technologies.</li>
<li>Adlai Nortye Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anl#NASDAQ">ANL</a>) gained 27.9% to $10.68.</li>
<li>Connexa Sports Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnxa#NASDAQ">CNXA</a>) surged 26.8% to $0.3801.</li>
<li>AXT, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axti#NASDAQ">AXTI</a>) rose 25.7% to $3.9089. AXT said it sees preliminary revenue of $22.4 million to $22.7 million for the first quarter.</li>
<li>Titan Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttnp#NASDAQ">TTNP</a>) climbed 24.4% to $8.70.</li>
<li>Apartment Income REIT Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/airc#NYSE">AIRC</a>) gained 22.6% to $38.47. Blackstone Real Estate will take AIR Communities private for approximately $10 billion.</li>
<li>GD Culture Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdc#NASDAQ">GDC</a>) rose 22% to $1.1195.</li>
<li>Outset Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/om#NASDAQ">OM</a>) gained 19.4% to $2.4492. BTIG analyst Maria Thibault initiated coverage on Outset Medical with a Buy rating and announced a price target of $6.</li>
<li>Dogness (International) Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dogz#NASDAQ">DOGZ</a>) gained 18.2% to $9.53.</li>
<li>Galmed Pharmaceuticals Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glmd#NASDAQ">GLMD</a>) rose 17.6% to $0.3999. Last week, Galmed Pharmaceuticals filed annual report on Form 20-F for the fiscal year ended Dec. 31, 2023.</li>
<li>Ducommun Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dco#NYSE">DCO</a>) surged 17.5% to $57.11 after the company confirmed that its Board of Directors received an unsolicited non-binding indication of interest from Albion River LLC.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) rose 13.8% to $6.60.</li>
<li>Perpetua Resources Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ppta#NASDAQ">PPTA</a>) climbed 13.5% to $5.40 after the company announced it received indication for up to $1.8 billion in financing from the Export-Import Bank of the United States for the Stibnite Gold Project.</li>
<li>AltC Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alcc#NASDAQ">ALCC</a>) gained 13.1% to $14.82. Oklo signed a LOI to supply 50 megawatts of power to Diamondback Energy.</li>
<li>WW International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ww#NASDAQ">WW</a>) rose 12.7% to $1.8697.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) gained 10.9% to $1,595.72 amid a rise in Bitcoin.</li>
<li>Model N, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/modn#NYSE">MODN</a>) rose 10.7% to $30.00 after the company announced it will be acquired by Vista Equity Partners for $1.25 billion.</li>
<li>A-Mark Precious Metals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amrk#NASDAQ">AMRK</a>) gained 10.3% to $36.10.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) surged 8.1% to $260.41 amid a rise in the price of Bitcoin.</li>
<li>BYND Cannasoft Enterprises Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcan#NASDAQ">BCAN</a>) gained 8% to $1.1119.</li>
<li>Antelope Enterprise Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehl#NASDAQ">AEHL</a>) shares rose 7.4% to $1.60 after declining 5% on Friday. On April 1, Antelope Enterprise announced preliminary full year 2023 revenue of $70.4 million.</li>
<li>Fastly, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fsly#NASDAQ">FSLY</a>) gained 5.9% to $13.27. Piper Sandler analyst James Fish upgraded Fastly from Neutral to Overweight and lowered the price target from $19 to $16.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>22nd Century Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xxii#NASDAQ">XXII</a>) fell 45.4% to $1.95. 22nd Century Group shares jumped over 140% on Friday after the company signed a new contract manufacturing agreement for the production of branded conventional cigarette products.</li>
<li>Perion Network Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/peri#NASDAQ">PERI</a>) dipped 36% to $13.51 after the company slashed FY24 revenue guidance.</li>
<li>MediaCo Holding Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdia#NASDAQ">MDIA</a>) fell 29.1% to $2.75. Shares of MediaCo Holding jumped 177% on Friday after a 13D amended filing showed Standard General L.P. reported a 95.2% stake in the company as of April 1, 2024.</li>
<li>SuperCom Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spcb#NASDAQ">SPCB</a>) fell 24.3% to $0.2175.</li>
<li>Selina Hospitality PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slna#NASDAQ">SLNA</a>) fell 23.7% to $0.0420.</li>
<li>DatChat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dats#NASDAQ">DATS</a>) fell 20.5% to $1.16.</li>
<li>HUB Cyber Security Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hubc#NASDAQ">HUBC</a>) dipped 18% to $1.26. HUB Cyber Security recently announced $8 million in financing via a straight debt arrangement.</li>
<li>Agenus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agen#NASDAQ">AGEN</a>) declined 17% to $0.4181. Agenus disclosed a 1-for-20 reverse stock split of common stock.</li>
<li>TRACON Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcon#NASDAQ">TCON</a>) fell 16.2% to $0.2139.</li>
<li>Conifer Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnfr#NASDAQ">CNFR</a>) dipped 15.9% to $0.8995. Cullen/Frost Bankers is scheduled to host a conference call on Thursday, April 25, 2024 to discuss first quarter 2024 earnings.</li>
<li>HWH International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hwh#NASDAQ">HWH</a>) fell 15.6% to $1.3408.</li>
<li>Murano Global Investments Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrno#NASDAQ">MRNO</a>) fell 11.8% to $9.79.</li>
<li>Globavend Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gvh#NASDAQ">GVH</a>) shares fell 11.2% to $1.4567 after jumping 57% on Friday.</li>
<li>CCSC Technology International Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cctg#NASDAQ">CCTG</a>) shares fell 11.2% to $3.00 after surging around 28% on Friday.</li>
<li>Reliance Global Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reli#NASDAQ">RELI</a>) fell 10.8% to $0.4327. Reliance Global, last week, reported FY23 earnings.</li>
<li>ZOOZ Power Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zooz#NASDAQ">ZOOZ</a>) fell 9.5% to $3.6675.</li>
<li>Douglas Dynamics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/plow#NYSE">PLOW</a>) fell 8.2% to $22.03. Baird analyst Timothy Wojs downgraded Douglas Dynamics from Outperform to Neutral and lowered the price target from $36 to $25.</li>
<li>Trump Media &amp; Technology Group Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/djt#NYSE">DJT</a>) fell 7.4% to $37.60.</li>
<li>Paramount Global (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/para#NASDAQ">PARA</a>) fell 7.1% to $11.12.</li>
<li>Dell Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dell#NYSE">DELL</a>) fell 4.1% to $127.22.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/04/38141299/this-analyst-with-86-accuracy-rate-sees-more-than-16-upside-in-intel-here-are-5-stock-picks-for-last"> This Analyst With 86% Accuracy Rate Sees More Than 16% Upside In Intel - Here Are 5 Stock Picks For Last Week From Wall Street&#39;s Most Accurate Analysts</a>

Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session

- SEC 13D/Amended Filing
&nbsp;
After giving effect to these changes in membership, as of April 2, 2024, four of the board's seven directors had been nominated by the reporting persons. The reporting persons expect to propose to the Issuer a business combination with KE Sdn. Bhd., a Malaysian company. Any such transaction would be subject to execution of definitive documents negotiated between the reporting persons and a committee of independent directors of the Issuer. This report does not constitute an offer of any securities for sale.

The Sire Group Ltd Says Expect To Propose To Titan Pharmaceuticals Inc A Business Combination With KE Sdn. Bhd

<h3>Gainers</h3>
<ul>
<li>Avalo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTX#NASDAQ">AVTX</a>) shares moved upwards by 215.8% to $15.0 during Wednesday's after-market session. The market value of their outstanding shares is at $12.0 million. </li>
<li>Fresh2 Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRES#NASDAQ">FRES</a>) stock moved upwards by 5.26% to $0.6. The company's market cap stands at $14.2 million. </li>
<li>Biora Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOR#NASDAQ">BIOR</a>) shares rose 5.12% to $1.23. The company's market cap stands at $33.4 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Athira Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHA#NASDAQ">ATHA</a>) stock rose 5.07% to $2.69. The market value of their outstanding shares is at $103.0 million. </li>
<li>Clearside Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) stock rose 4.79% to $1.75. The company's market cap stands at $130.7 million. </li>
<li>TFF Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TFFP#NASDAQ">TFFP</a>) stock increased by 4.7% to $6.9. The market value of their outstanding shares is at $16.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Strata Skin Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSKN#NASDAQ">SSKN</a>) stock fell 12.5% to $0.39 during Wednesday's after-market session. The market value of their outstanding shares is at $13.6 million. As per the press release, Q4 earnings came out today. </li>
<li>Yield10 Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YTEN#NASDAQ">YTEN</a>) stock declined by 9.36% to $0.34. The company's market cap stands at $4.0 million. </li>
<li>Modular Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MODD#NASDAQ">MODD</a>) stock declined by 9.24% to $1.77. The company's market cap stands at $54.8 million. </li>
<li>GlycoMimetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLYC#NASDAQ">GLYC</a>) stock fell 8.81% to $2.9. The company's market cap stands at $186.7 million. As per the news, the Q4 earnings report came out today. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares fell 5.15% to $7.0. The market value of their outstanding shares is at $5.2 million. </li>
<li>Alzamend Neuro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALZN#NASDAQ">ALZN</a>) stock declined by 5.01% to $0.99. The company's market cap stands at $6.5 million. The company's, Q3 earnings came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALZN

ATHA

AVTX

BIOR

CLSD

FRES

MODD

SSKN

TFFP

YTEN

12 Health Care Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Apollomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLM#NASDAQ">APLM</a>) stock rose 10.9% to $0.61 during Tuesday's after-market session. The market value of their outstanding shares is at $54.5 million. </li>
<li>Cara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares moved upwards by 7.36% to $0.78. The company's market cap stands at $42.8 million. </li>
<li>Coeptis Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COEP#NASDAQ">COEP</a>) shares moved upwards by 6.66% to $0.32. The company's market cap stands at $10.9 million. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares rose 6.44% to $7.75. The market value of their outstanding shares is at $5.8 million. </li>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) shares increased by 6.38% to $0.5. The market value of their outstanding shares is at $4.6 million. </li>
<li>Iridex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRIX#NASDAQ">IRIX</a>) stock increased by 5.52% to $2.65. The company's market cap stands at $43.0 million. The company's, Q4 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Akili (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKLI#NASDAQ">AKLI</a>) stock decreased by 22.9% to $0.29 during Tuesday's after-market session. The company's market cap stands at $23.0 million. </li>
<li>Mira Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIRA#NASDAQ">MIRA</a>) stock fell 11.34% to $1.02. The company's market cap stands at $15.0 million. </li>
<li>Estrella Immunopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESLA#NASDAQ">ESLA</a>) shares decreased by 9.84% to $1.1. The market value of their outstanding shares is at $40.2 million. </li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) shares decreased by 7.21% to $3.6. The market value of their outstanding shares is at $4.2 million. </li>
<li>United Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTHR#NASDAQ">UTHR</a>) shares declined by 7.21% to $230.0. The company's market cap stands at $10.8 billion. </li>
<li>ProSomnus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSA#NASDAQ">OSA</a>) stock decreased by 6.46% to $0.58. The market value of their outstanding shares is at $10.0 million. As per the press release, Q4 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKLI

APLM

BSGM

CARA

COEP

ESLA

IRIX

MIRA

UTHR

VRPX

12 Health Care Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Fresh2 Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRES#NASDAQ">FRES</a>) shares rose 41.7% to $0.66 during Monday's regular session. The market value of their outstanding shares is at $15.7 million. </li>
<li>Akso Health Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHG#NASDAQ">AHG</a>) stock moved upwards by 29.0% to $1.29. The company's market cap stands at $141.3 million. </li>
<li>ChromaDex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXC#NASDAQ">CDXC</a>) stock moved upwards by 27.91% to $3.07. The company's market cap stands at $231.1 million. </li>
<li>Elicio Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTX#NASDAQ">ELTX</a>) stock moved upwards by 24.0% to $6.2. The market value of their outstanding shares is at $59.5 million. </li>
<li>Immuneering (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMRX#NASDAQ">IMRX</a>) stock increased by 23.04% to $2.35. The company's market cap stands at $68.8 million. </li>
<li>Biotricity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTCY#NASDAQ">BTCY</a>) stock rose 21.08% to $1.55. The company's market cap stands at $14.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Trxade Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDS#NASDAQ">MEDS</a>) shares declined by 33.0% to $19.3 during Monday's regular session. The market value of their outstanding shares is at $23.2 million. </li>
<li>Envoy Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCH#NASDAQ">COCH</a>) shares declined by 27.6% to $3.62. The market value of their outstanding shares is at $70.7 million. </li>
<li>CareMax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMAX#NASDAQ">CMAX</a>) shares decreased by 25.28% to $4.14. The market value of their outstanding shares is at $15.5 million. The company's, Q4 earnings came out today. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares fell 18.34% to $7.59. The market value of their outstanding shares is at $5.7 million. </li>
<li>Cargo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGX#NASDAQ">CRGX</a>) stock declined by 17.67% to $25.75. The company's market cap stands at $1.0 billion. </li>
<li>Molecular Templates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEM#NASDAQ">MTEM</a>) shares fell 17.28% to $2.27. The market value of their outstanding shares is at $12.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BTCY

CDXC

CMAX

Envoy Medical, Inc. - Class A Common Stock

COCH

CRGX

ELTX

IMRX

MEDS

MTEM

<h3>Gainers</h3>
<ul>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) stock moved upwards by 33.1% to $0.49 during Monday's pre-market session. The market value of their outstanding shares is at $8.3 million. </li>
<li>XTL Biopharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTLB#NASDAQ">XTLB</a>) shares increased by 19.31% to $1.05. The market value of their outstanding shares is at $5.7 million. </li>
<li>2seventy bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSVT#NASDAQ">TSVT</a>) shares rose 17.7% to $4.72. The company's market cap stands at $242.1 million. </li>
<li>DBV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBVT#NASDAQ">DBVT</a>) shares moved upwards by 13.92% to $0.9. The company's market cap stands at $173.1 million. </li>
<li>Elicio Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTX#NASDAQ">ELTX</a>) shares increased by 13.2% to $5.66. The market value of their outstanding shares is at $54.3 million. </li>
<li>Moleculin Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) stock rose 12.53% to $0.56. The company's market cap stands at $18.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares declined by 18.2% to $7.6 during Monday's pre-market session. The market value of their outstanding shares is at $5.7 million. </li>
<li>Biophytis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTS#NASDAQ">BPTS</a>) stock fell 14.6% to $0.41. The market value of their outstanding shares is at $3.9 million. </li>
<li>Molecular Templates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEM#NASDAQ">MTEM</a>) shares decreased by 14.19% to $2.36. The company's market cap stands at $12.6 million. </li>
<li>Nanobiotix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBTX#NASDAQ">NBTX</a>) shares fell 9.36% to $6.3. The market value of their outstanding shares is at $296.8 million. </li>
<li>TC BioPharm (Holdings) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) stock fell 8.92% to $1.53. The company's market cap stands at $3.7 million. </li>
<li>Trxade Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDS#NASDAQ">MEDS</a>) shares decreased by 8.82% to $26.26. The company's market cap stands at $31.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BPTS

DBVT

MBRX

NBTX

TSVT

XTLB

12 Health Care Stocks Moving In Monday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) stock rose 122.5% to $4.05 during Thursday's pre-market session. The company's market cap stands at $2.2 million. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) stock moved upwards by 27.59% to $8.0. The company's market cap stands at $6.0 million. </li>
<li>Trxade Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDS#NASDAQ">MEDS</a>) shares rose 18.73% to $5.32. The company's market cap stands at $6.4 million. </li>
<li>Elicio Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTX#NASDAQ">ELTX</a>) shares moved upwards by 17.8% to $3.97. The company's market cap stands at $38.1 million. </li>
<li>Nutex Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUTX#NASDAQ">NUTX</a>) stock increased by 17.63% to $0.13. The market value of their outstanding shares is at $97.9 million. </li>
<li>Mineralys Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLYS#NASDAQ">MLYS</a>) shares rose 16.51% to $14.53. The market value of their outstanding shares is at $597.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Jin Medical International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJYL#NASDAQ">ZJYL</a>) shares decreased by 93.9% to $13.26 during Thursday's pre-market session. The market value of their outstanding shares is at $103.7 million. </li>
<li>Tenax Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENX#NASDAQ">TENX</a>) shares fell 52.39% to $6.79. The company's market cap stands at $2.3 million. </li>
<li>InVivo Therapeutics Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVIV#NASDAQ">NVIV</a>) stock declined by 17.61% to $0.53. The company's market cap stands at $1.6 million. </li>
<li>HOOKIPA Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOK#NASDAQ">HOOK</a>) shares declined by 13.6% to $0.58. The market value of their outstanding shares is at $57.6 million. </li>
<li>ThermoGenesis Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THMO#NASDAQ">THMO</a>) shares fell 13.1% to $0.73. The company's market cap stands at $2.2 million. </li>
<li>Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) stock declined by 13.02% to $0.59. The company's market cap stands at $5.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HOOK

MLYS

NUTX

NVIV

TENX

THMO

XCUR

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Titan Pharmaceuticals Says Fully Compliant With NASDAQ Listing Criteria

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Titan Pharma Stock (NASDAQ:TTNP), Short Interest Report

People Also Watch